History
Lombard Medical is a medical technology company specializing in the development, manufacture, and marketing of endovascular stent-grafts designed to address significant unmet needs in aortic aneurysm repair.
The company focuses on solutions for the abdominal aortic aneurysm (AAA) repair market, which generates annual revenues of $1.4 billion. Its flagship product, Aorfix™, is an endovascular stent-graft specifically designed to address the challenges of treating complex, tortuous anatomies often present in advanced stages of AAA disease.
Aorfix is the only endovascular stent-graft approved by the U.S. Food and Drug Administration (FDA) and the Japanese Ministry of Health, Labour and Welfare for treating AAAs with neck angles of up to 90 degrees.
The company focuses on solutions for the abdominal aortic aneurysm (AAA) repair market, which generates annual revenues of $1.4 billion. Its flagship product, Aorfix™, is an endovascular stent-graft specifically designed to address the challenges of treating complex, tortuous anatomies often present in advanced stages of AAA disease.
Aorfix is the only endovascular stent-graft approved by the U.S. Food and Drug Administration (FDA) and the Japanese Ministry of Health, Labour and Welfare for treating AAAs with neck angles of up to 90 degrees.
Request a callback